• Corpus ID: 28562978

Defense mechanisms against influenza virus infection in the respiratory tract mucosa.

  title={Defense mechanisms against influenza virus infection in the respiratory tract mucosa.},
  author={Shin‐ichi Tamura and Takeshi Kurata},
  journal={Japanese journal of infectious diseases},
  volume={57 6},
  • S. Tamura, T. Kurata
  • Published 1 December 2004
  • Biology
  • Japanese journal of infectious diseases
The respiratory tract mucosa is not only the site of infection for influenza viruses but also the site of defense against virus infection. [] Key Result The IgG Abs, which transude from the serum to the mucus by diffusion, provide protection against homologous virus infection. They are largely distributed on the alveolar epithelia to prevent influenza pneumonia.

Figures from this paper

Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.

Natural infection is well known to be superior to parenteral inactivated vaccines in inducing the broad-spectrum cross-protection and many trials have been conducted to mimic natural infection, including intranasal or epidermal administration of inactivated vaccine with or without an adjuvant.

Pulmonary immunity to viruses.

Immune responses to respiratory viral infections must be strong enough to eliminate infection, but also have mechanisms to limit damage and promote tissue repair in order to maintain pulmonary homeostasis.

Immune Responses to Influenza Virus and Its Correlation to Age and Inherited Factors

The different components of immune responses against influenza virus are reviewed to lead to a better understanding of the limitations ofimmune responses for developing improved vaccines to control influenza virus infection.

Disruption of nasal bacteria enhances protective immune responses to influenza A virus and SARS-CoV-2 infection in mice

It is demonstrated that while intranasal administration of influenza virus hemagglutinin vaccine alone was insufficient to induce the vaccine-specific antibody responses, disruption of nasal bacteria by lysozyme or addition of culturable oral bacteria from a healthy human volunteer rescued inability of the nasal bacteria to generate antibody responses to intranal administered the split-virus vaccine.

Respiratory Epithelial Cells in Innate Immunity against Respiratory Viruses

The role of the RE cells as innate immunity mediator is analyzed and the potential use of this knowledge in the development of future mucosal therapies and vaccination is discussed.

Roles of Mucosal Immunity against Mycobacterium tuberculosis Infection

The current state of knowledge regarding the mucosal immunity against Mtb infection, including the development of TB vaccines, and respiratory delivery routes to enhance mucosal Immunity are discussed are outlined.

The Airway Epithelium: Soldier in the Fight against Respiratory Viruses

SUMMARY The airway epithelium acts as a frontline defense against respiratory viruses, not only as a physical barrier and through the mucociliary apparatus but also through its immunological

Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?

Data suggest that adjuvant-combined nasal-inactivated vaccines have advantages over the current injectable vaccine because the former induce both S-IgA and serum IgG Abs, and non-infectious preparations could be used in high-risk groups.

Nanoparticle vaccines against respiratory viruses

  • B. Adair
  • Biology
    Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
  • 2009
Nanoparticle vaccines, incorporating antigenic components from influenza, RSV, or PI‐3V have been shown to be capable of stimulating mucosal and systemic immune responses, which can prevent the spread of infection to the lower respiratory tract.



Passive transfer of local immunity to influenza virus infection by IgA antibody.

The passive transfer of local immunity by the i.v. administration of pIgA antibody is demonstrated and it is shown that the IgA in secretions can protect against influenza virus infection.

Secretory anti-influenza immunity.

The Role of Alpha/Beta and Gamma Interferons in Development of Immunity to Influenza A Virus in Mice

Observations reveal no significant contribution for IFN-controlled pathways in shaping acute or memory T-cell responses to pneumotropic influenza virus infection but do indicate some role forIFN-α/β in the regulation of antibody responses.

Gamma Interferon Is Not Required for Mucosal Cytotoxic T-Lymphocyte Responses or Heterosubtypic Immunity to Influenza A Virus Infection in Mice

It is conclusively show that IFN-γ is not required for induction of secondary influenza virus-specific CTL responses in mediastinal lymph nodes and HSI to lethal influenza A virus infection.

Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus

This report shows that adoptive transfer of primary or secondary immune spleen cells to mice inoculated intranasally with a lethal dose of A/WSN virus caused a significant reduction of infectious virus levels in the lungs and prevented death.

Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production.

It is suggested thatinterferon plays an important role in the transition from the first phase to the second, and that T cells are required for interferon induction in mice infected with influenza virus.

Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.

In parallel with the detection of AFCs in infected mice, virus-specific IgA antibodies appeared in the nasal wash and their appearance correlated well with virus clearance from the nasal area, suggesting that virus- specific IgA proteins play an important role in recovery from infection.

Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.

A virus-specific Tc cell response is not a requirement for recovery from a pulmonary influenza virus infection, compatible with virus clearance being effected either directly after recognition of infected class II-positive cells by the transferred Th cells or indirectly via promotion of a glycoprotein-specific antibody response.

Heterosubtypic Immunity to Influenza A Virus in Mice Lacking IgA, All Ig, NKT Cells, or γδ T Cells1

The results in Ig−/− mice indicate that CD4+ T cells can function by mechanisms other than providing help to B cells for the generation of Abs, and demonstrate that each may play a role in a multifaceted response that as a whole is more effective than any of its parts.